OSR HEALTH, INC.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | — | $2.9M | $3.5M | — | — | — |
| Cost of Revenue | — | $2.3M | $2.7M | — | — | — |
| Gross Profit | — | $592.9K | $811.2K | — | — | — |
| Gross Margin | — | 20.4% | 23.0% | — | — | — |
| Operating Expenses | ||||||
| Research & Development | — | $318.4K | $161.2K | — | — | — |
| SG&A Expense | — | $18.9M | $12.5M | $1.8M | $35.4K | $3.3K |
| Operating Income | — | $-18.3M | $-11.7M | $-1.8M | $-35.4K | $-3.3K |
| Operating Margin | — | -631.0% | -331.2% | — | — | — |
| Interest Expense | — | — | — | — | — | — |
| Pretax Income | — | $-28.9M | $-11.9M | $944.6K | — | — |
| Income Tax Expense | — | $-1.8M | $-1.6M | $540.8K | — | — |
| Net Income | — | $-27.1M | $-2.4M | $403.8K | $-35.4K | $-3.3K |
| Net Margin | — | -931.2% | -68.3% | — | — | — |
| EPS (Basic) | — | $-0.92 | $-0.48 | $0.01 | $0.00 | $0.00 |
| EPS (Diluted) | — | $-0.80 | $-0.48 | $0.01 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 33.1M | 19.5M | 21.6M | 76.9M | 75.0M | 86.3M |
| Shares Outstanding (Diluted) | 33.1M | 22.6M | 21.6M | 77.2M | 75.0M | 86.3M |
| Dividends Per Share | — | — | — | — | — | — |